Whenever you get a cut, an injury, big or small, your body immediately goes into the process of healing it. So, how does it ...

Colon cancer continues to be one of the leading causes of cancer-related deaths worldwide, with poor dietary habits ...

The CIDS Phase III was a multicenter, multinational, randomized, controlled, open label study, conducted in pediatric patients with deep partial thickness (DPT) and full thickness (FT) thermal ...

MediWound (MDWD) announced the publication of its Phase III Children Innovative Debridement Study in Burns, the peer-reviewed Journal of the International Society for Burn Injuries. The study ...

Phase II clinical trials have shown EscharEx has distinct advantages over the currently available $375+ million drug for wound debridement, presenting a unique opportunity for significant market ...

This includes a 2022 study involving rats which found that whey protein accelerated the entire wound-healing process, speeding the transition from the inflammatory phase to the proliferative phase ...

and MIMEDX to provide advanced products for consistent wound management. In addition to the VALUE study, MediWound is preparing for a head-to-head Phase II study comparing EscharEx to collagenase for ...

and MIMEDX to provide advanced products for consistent wound management. In addition to the VALUE study, MediWound is preparing for a head-to-head Phase II study comparing EscharEx to collagenase ...